We report the case of an 82-year old Italian female with laryngeal involvement of classic Kaposi's sarcoma. We obtained a complete regression of laryngeal lesion with low-dose alpha-2b interferon.
Get full access to this article
View all access options for this article.
References
1.
BatsakisJ.G.: Tumors of the head and neck. pp. 305–307, William and Wilkins, Baltimore, 1974.
2.
BourlondA., DuboisD., De SelysR.: Sarcome de Kaposi: traitment par facteur de transfert et interferon-alpha-2.Dermatologica, 174: 199–200, 1987.
3.
ContuL., SulisE., CerimeleD., CarcassiC., La NasaG., PintusA., PitzusF.: The role of alpha-interferon in the therapy of Kaposi's sarcoma (AIDS and classic forms) and of cutaneous T-cell lymphomas. New Trends Ther.Leuk. Lymph., 2: 83–88, 1987.
4.
CoyasA., EliadellisE., AnastassiadesO.: Kaposi's sarcoma of the larynx.J. Larynx Otol., 97: 647–649, 1983.
5.
GelmannE.P., PrebleO.T., SteisR., LaneH.C., RookA.H., WesleyM., JacobS., FauciA., MasurH., LongoD.: Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome.Am. J. Med., 78: 734–741, 1985.
6.
GroopmanJ.E.: Biology and therapy of epidemic Kaposi's sarcoma.Cancer, 59: 633–637, 1987.
